| ITALY |
WP4 |
| Organization |
University of Verona |
| Name of cohort |
UNIVR - Haematological patients |
| Referring partner |
UNIVR |
| Cohort Information |
Country(-ies), cities, regions or centers involved |
Verona, Italy |
| Time of data collection |
04/2022
|
Ongoing
|
| Enrolment |
Inactive |
| Study setting |
Single center |
| Population |
Age |
Adults |
| Type |
Prospective |
| Total number of patients |
370 |
| Type of frailty (WP4) |
Hematological
|
| Data collection |
Clinical data |
True |
| Serological data |
True |
| Genetic data |
False |
| Sample collection |
True |
| Sample collected |
Whole blood |
Yes
|
| PBMC |
No
|
| Dry-spot blood |
No
|
| Plasma |
No
|
| Serum |
No
|
| Stool |
No
|
| NP swabs |
No
|
| Other |
None
|
| Description |
Aim of the task is to evaluate in hematological patients the risk of COVID-19 clinical progression compared to both the general population and to patients with solid cancer. |
| Publications |
- Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis [Hematological Oncology]
|